Melanoma Immune Oncology Research Group – Improving Immunotherapy for Metastatic Cutaneous and Uveal Melanomas

September 29, 2020July 3, 2021

Welcome to MIORG, hosted by CANCERLAB, University of Turku, Finland.

MIORGFollow

https://www.utu.fi/fi/ajankohtaista/uutinen/suomen-akatemia-myonsi-turun-yliopistolle-lahes-kolme-miljoonaa-euroa?fbclid=IwAR1w9p-Z0k31w9b8WxrUR3tx2URD-Zep6ZIpk6-E2UK4rpQGrhObsZSowEE

Reply on Twitter 1369989688405147651 Retweet on Twitter 1369989688405147651 Like on Twitter 1369989688405147651 Twitter 1369989688405147651

MIORG @Roger84058338·

26 Jan

https://www.youtube.com/watch?v=_VhcZTGv0CU

Reply on Twitter 1354054504182853632 Retweet on Twitter 1354054504182853632 Like on Twitter 1354054504182853632 Twitter 1354054504182853632

MIORG @Roger84058338·

26 Oct

A new study from researchers in Finland and the United Kingdom reveals that tumours lacking a protein called BAP1 have an ineffective immune reaction against cancer, thus rendering immunotherapies ineffectual, particularly in uveal melanomas (UM).
https://bit.ly/3juGzwb

Reply on Twitter 1320630653847744514 Retweet on Twitter 13206306538477445142 Like on Twitter 1320630653847744514 Twitter 1320630653847744514